![Activation of Transcription by Estrogen Receptor α and β Is Cell Type- and Promoter-dependent* - Journal of Biological Chemistry Activation of Transcription by Estrogen Receptor α and β Is Cell Type- and Promoter-dependent* - Journal of Biological Chemistry](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/e2893789-f30d-4d6e-90f9-b3fcef6084d5/gr1_lrg.jpg)
Activation of Transcription by Estrogen Receptor α and β Is Cell Type- and Promoter-dependent* - Journal of Biological Chemistry
![Molecular mechanism of estrogen–estrogen receptor signaling - Yaşar - 2017 - Reproductive Medicine and Biology - Wiley Online Library Molecular mechanism of estrogen–estrogen receptor signaling - Yaşar - 2017 - Reproductive Medicine and Biology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/0c531b1c-96bf-44d2-b1bf-dcf2c33e92b2/rmb212006-fig-0001-m.jpg)
Molecular mechanism of estrogen–estrogen receptor signaling - Yaşar - 2017 - Reproductive Medicine and Biology - Wiley Online Library
![Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action | British Journal of Cancer Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action | British Journal of Cancer](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fsj.bjc.6601629/MediaObjects/41416_2004_Article_BF6601629_Fig3_HTML.jpg)
Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action | British Journal of Cancer
![Targeted degradation of activating estrogen receptor α ligand-binding domain mutations in human breast cancer | SpringerLink Targeted degradation of activating estrogen receptor α ligand-binding domain mutations in human breast cancer | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10549-020-05564-y/MediaObjects/10549_2020_5564_Fig5_HTML.png)
Targeted degradation of activating estrogen receptor α ligand-binding domain mutations in human breast cancer | SpringerLink
![Targeted degradation of activating estrogen receptor α ligand-binding domain mutations in human breast cancer | SpringerLink Targeted degradation of activating estrogen receptor α ligand-binding domain mutations in human breast cancer | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10549-020-05564-y/MediaObjects/10549_2020_5564_Fig2_HTML.png)
Targeted degradation of activating estrogen receptor α ligand-binding domain mutations in human breast cancer | SpringerLink
![Transcriptional repression of estrogen receptor alpha by YAP reveals the Hippo pathway as therapeutic target for ER+ breast cancer | Nature Communications Transcriptional repression of estrogen receptor alpha by YAP reveals the Hippo pathway as therapeutic target for ER+ breast cancer | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-022-28691-0/MediaObjects/41467_2022_28691_Fig1_HTML.png)
Transcriptional repression of estrogen receptor alpha by YAP reveals the Hippo pathway as therapeutic target for ER+ breast cancer | Nature Communications
![Estrogen receptor functional domains and signal transduction schemes.... | Download Scientific Diagram Estrogen receptor functional domains and signal transduction schemes.... | Download Scientific Diagram](https://www.researchgate.net/profile/Peter-Van-Dam-2/publication/230828354/figure/fig1/AS:202778975707152@1425357683725/Estrogen-receptor-functional-domains-and-signal-transduction-schemes-a-Different_Q640.jpg)
Estrogen receptor functional domains and signal transduction schemes.... | Download Scientific Diagram
![Frontiers | Involvement of the Estrogen and Progesterone Axis in Cancer Stemness: Elucidating Molecular Mechanisms and Clinical Significance | Oncology Frontiers | Involvement of the Estrogen and Progesterone Axis in Cancer Stemness: Elucidating Molecular Mechanisms and Clinical Significance | Oncology](https://www.frontiersin.org/files/Articles/570192/fonc-10-01657-HTML/image_m/fonc-10-01657-g001.jpg)
Frontiers | Involvement of the Estrogen and Progesterone Axis in Cancer Stemness: Elucidating Molecular Mechanisms and Clinical Significance | Oncology
![Targeting estrogen receptor α for degradation with PROTACs: A promising approach to overcome endocrine resistance - ScienceDirect Targeting estrogen receptor α for degradation with PROTACs: A promising approach to overcome endocrine resistance - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0223523420306619-gr6.jpg)
Targeting estrogen receptor α for degradation with PROTACs: A promising approach to overcome endocrine resistance - ScienceDirect
![Identification of pathway-selective estrogen receptor ligands that inhibit NF-κB transcriptional activity | PNAS Identification of pathway-selective estrogen receptor ligands that inhibit NF-κB transcriptional activity | PNAS](https://www.pnas.org/content/pnas/102/7/2543/F4.large.jpg)
Identification of pathway-selective estrogen receptor ligands that inhibit NF-κB transcriptional activity | PNAS
![Regulation of estrogen receptor signaling in breast carcinogenesis and breast cancer therapy. - Abstract - Europe PMC Regulation of estrogen receptor signaling in breast carcinogenesis and breast cancer therapy. - Abstract - Europe PMC](https://europepmc.org/articles/PMC3962223/bin/nihms-489031-f0001.jpg)
Regulation of estrogen receptor signaling in breast carcinogenesis and breast cancer therapy. - Abstract - Europe PMC
![Targeted degradation of activating estrogen receptor α ligand-binding domain mutations in human breast cancer | SpringerLink Targeted degradation of activating estrogen receptor α ligand-binding domain mutations in human breast cancer | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10549-020-05564-y/MediaObjects/10549_2020_5564_Fig3_HTML.png)
Targeted degradation of activating estrogen receptor α ligand-binding domain mutations in human breast cancer | SpringerLink
![Cancers | Free Full-Text | Natural and Synthetic Estrogens in Chronic Inflammation and Breast Cancer | HTML Cancers | Free Full-Text | Natural and Synthetic Estrogens in Chronic Inflammation and Breast Cancer | HTML](https://www.mdpi.com/cancers/cancers-14-00206/article_deploy/html/images/cancers-14-00206-g001.png)
Cancers | Free Full-Text | Natural and Synthetic Estrogens in Chronic Inflammation and Breast Cancer | HTML
![Estrogen receptor functional domains and signal transduction schemes.... | Download Scientific Diagram Estrogen receptor functional domains and signal transduction schemes.... | Download Scientific Diagram](https://www.researchgate.net/profile/Peter-Van-Dam-2/publication/230828354/figure/fig5/AS:202778975707158@1425357683822/Transrepression-of-estrogen-receptor-and-NFkB-a-NFkB-can-inhibit-estrogen-receptor_Q320.jpg)
Estrogen receptor functional domains and signal transduction schemes.... | Download Scientific Diagram
![Frontiers | G Protein-Coupled Estrogen Receptor: A Potential Therapeutic Target in Cancer | Endocrinology Frontiers | G Protein-Coupled Estrogen Receptor: A Potential Therapeutic Target in Cancer | Endocrinology](https://www.frontiersin.org/files/MyHome%20Article%20Library/490587/490587_Thumb_400.jpg)
Frontiers | G Protein-Coupled Estrogen Receptor: A Potential Therapeutic Target in Cancer | Endocrinology
![Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways in: Journal of Molecular Endocrinology Volume 41 Issue 5 (2008) Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways in: Journal of Molecular Endocrinology Volume 41 Issue 5 (2008)](https://jme.bioscientifica.com/view/journals/jme/41/5/images/large/263fig2.jpeg)
Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways in: Journal of Molecular Endocrinology Volume 41 Issue 5 (2008)
![A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling.,Cell Chemical Biology - X-MOL A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling.,Cell Chemical Biology - X-MOL](https://xpic.x-mol.com/20191110%2F10.1016_j.chembiol.2019.10.009.jpg)
A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling.,Cell Chemical Biology - X-MOL
![The NF-KB pathway and endocrine therapy resistance in breast cancer in: Endocrine-Related Cancer Volume 26 Issue 6 (2019) The NF-KB pathway and endocrine therapy resistance in breast cancer in: Endocrine-Related Cancer Volume 26 Issue 6 (2019)](https://erc.bioscientifica.com/view/journals/erc/26/6/images/full-ERC-19-0087fig1.jpeg)